Earl F. Albone
- Oncology top 10%
- HER2/EGFR in Cancer Research 9
- Cancer Treatment and Pharmacology 4
- Cancer-related Molecular Pathways 3
-
- Monoclonal and Polyclonal Antibodies Research 12
- Radiopharmaceutical Chemistry and Applications 3
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment 3
-
- Click Chemistry and Applications 4
-
- Glycosylation and Glycoproteins Research 7
- Co-authors
- Xin ChengLuigi GrassoNicholas C. NicolaidesJared SpidelKatherine A. RybinskiJ. Bradford KlineShawn FernandoFred K. Hagen
- Journals
- Journal of the American Chemical Society (1 paper)Journal of Biological Chemistry (1 paper)Cancer Research (4 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Earl F. Albone
35 papers receiving 687 citations
Peers
Comparison fields: 5 of 82
- Oncology 241
- Radiology, Nuclear Medicine and Imaging 180
- Reproductive Medicine 43
- Organic Chemistry 144
- Biotechnology 43
Countries citing papers authored by Earl F. Albone
This map shows the geographic impact of Earl F. Albone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Earl F. Albone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Earl F. Albone more than expected).
Fields of papers citing papers by Earl F. Albone
This network shows the impact of papers produced by Earl F. Albone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Earl F. Albone. The network helps show where Earl F. Albone may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Earl F. Albone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2020 | 1 | |
| 3 | 2019 | 34 | |
| 4 | 2019 | 5 | |
| 5 | 2018 | 75 | |
| 6 | 2018 | 1 | |
| 7 | 2017 | 15 | |
| 8 | 2017 | 36 | |
| 9 | 2017 | 12 | |
| 10 | 2016 | 23 | |
| 11 | 2014 | 22 | |
| 12 | 2013 | 43 | |
| 13 | 2011 | 26 | |
| 14 | 2009 | 47 | |
| 15 | 2006 | 6 | |
| 16 | 2006 | 9 | |
| 17 | 2005 | 7 | |
| 18 | 2005 | 7 | |
| 19 | 1996 | 2 | |
| 20 | 1994 | 23 |
About Earl F. Albone
Earl F. Albone is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Reproductive Medicine, having authored 35 papers that have together received 729 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), HER2/EGFR in Cancer Research (9 papers), Glycosylation and Glycoproteins Research (7 papers), Click Chemistry and Applications (4 papers), Cancer Treatment and Pharmacology (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Cancer-related Molecular Pathways (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Oncology (241 citations), Radiology, Nuclear Medicine and Imaging (180 citations) and Reproductive Medicine (43 citations). Earl F. Albone has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Xin Cheng, Luigi Grasso, Nicholas C. Nicolaides, Jared Spidel, Katherine A. Rybinski, J. Bradford Kline, Shawn Fernando, Fred K. Hagen, Lawrence A. Tabak and Elizabeth B. Somers. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.